Big pharmaceutical companies strike licensing deals with small companies in hopes of finding new, highly profitable medicine without the cost of buying a whole company.
Small companies get funding other ways, such as venture capital firms, but the money from licensing arrangements can mean the difference between continuing operations and closing shop.
{iframe}http://medcitynews.com/2013/06/what-are-pharmaceutical-companies-looking-for-in-a-licensing-deal/{/iframe}